ESC 365 - Serum sLOX-1 concentrations are associated with 2- year major adverse cardiovascular and cerebrovascular events in patients after percutaneous coronary intervention: A multicenter pilot study

ESC Premium Access

Serum sLOX-1 concentrations are associated with 2- year major adverse cardiovascular and cerebrovascular events in patients after percutaneous coronary intervention: A multicenter pilot study

Session: Poster Session 2 - Acute Coronary Syndromes: Biomarkers

Topic: Biomarkers

Speaker: Doctor Z. Zhao (Fuzhou, CN)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Zi-Wen Zhao

Union Hospital, Fujian Medical University,, Fuzhou (China)

0 follower

6 more presentations in this session

Novel biomarker algorithmic panel measuring permutations of immune response to cardiac endothelial injury and global risk factors identifies patients at risk of acute coronary syndrome (ACS)

Speaker: Professor D. Harrington (Irvine, US)

Plasma proteomics in healthy individuals predict myocardial infarction

Speaker: Ms R. Hoogeveen (Amsterdam, NL)

The protein APRIL predicts adverse outcomes in DAPT patients better than NT-proBNP and troponin

Speaker: Professor C. Pemberton (Christchurch, NZ)

GLP-1 levels predict cardiovascular risk in patients with acute myocardial infarction

Speaker: Doctor M. Lehrke (Aachen, DE)

The novel small leucin-rich repeat protein podocan is an independent predictor of major adverse cardiac events in patients with angiographically-defined coronary artery disease

Speaker: Doctor K. watthanasuntorn (Cooperstown, US)

Access the full session

Poster Session 2 - Acute Coronary Syndromes: Biomarkers

Speakers: Doctor Z. Zhao, Professor D. Harrington, Ms R. Hoogeveen, Professor C. Pemberton, Doctor M. Lehrke...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources